Value of Medication Adherence in Polycythemia Vera

Emily A. Knight, RN

Video Categories: Polycythemia Vera

Listen as Emily Knight discusses why medication adherence and educating patients with polycythemia vera is important

Supported through funding from Incyte
July 13, 2021

Occurrence of TRK Fusion–Positive Tumors in Different Cancer Types

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, confer on the categorization of various cancer types in which NTRK gene fusions may be detected.

January 30, 2014

The Value Equation and Personalized Medicine

Dr Argawala discusses how the cost, access and quality of oncology care will be defined with new personalized medicine strategies and therapies.